Ben Urick, PharmD, PhD, examines GLP-1 coverage gaps and real-world evidence challenges shaping payer decisions and obesity ...
World Hemophilia Day spotlights the rare blood disorder that prevents the blood from clotting and can be dangerous when left ...
High co-payments for potentially curative cell and gene therapies create avoidable access barriers; value-based insurance design should eliminate patient cost sharing for these therapies. 259 Prospect ...
The investigators explained that GLP-1 receptor agonists appear to be able to help resolve MASH without worsening fibrosis. Those findings have been confirmed in mouse models and in multiple studies ...
Many patients with scarring alopecia say they feel more confident in their care when they see a dermatologist who is a hair ...
Hayley Knollman, MD, explains how ctDNA and genomic testing impact ER-positive metastatic breast cancer care, guiding ...
FDA is encouraging supplemental NDAs for TRT to treat low libido in idiopathic hypogonadism, reflecting preliminary ...
High co-payments for potentially curative cell and gene therapies create avoidable access barriers; value-based insurance ...
With oncology now the largest cost center for health plans, experts at the Academy of Managed Care Pharmacy (AMCP) 2026 ...
Metabolic disease is reshaping care delivery and costs, with experts at the Academy of Managed Care Pharmacy (AMCP) 2026 ...
The FDA will convene an expert advisory panel in July 2026 to evaluate whether certain peptides should become more widely ...
At AMCP 2026, Daryl Pritchard, PhD, highlighted fragmentation, evidence gaps, and decision support needs limiting precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results